一线视角:某药学部对COVID-19疫情的应对
本报告回顾性描述某机构在2020年4月1日至15日期间,通过电子病历中嵌入的COVID-19专属care bundle标准化药学流程并部署药师资源。研究期内197例患者共记录1,572次药师干预,平均每例8次,最常见为方案简化、时机与剂量调整及抗菌药物与COVID-19治疗调整。
要点
- 药师干预覆盖方案简化、剂量调整与抗感染治疗调整等多类用药问题
- ICU患者占全部记录干预的66.7%,提示重症患者用药管理需求集中
- 将COVID-19专属care bundle整合入电子病历可标准化药学监护与干预记录
核心结论
- 药学部通过标准化流程优化了对COVID-19疫情的应对,药师针对广泛的用药相关问题进行干预,可能有助于改善COVID-19患者管理。
研究设计与样本
- 回顾性描述性报告,统计2020年4月1日至4月15日因COVID-19住院的急性期成人患者中记录的药师干预,并通过电子病历中COVID-19专属care bundle促进患者监护、跨专业沟通与干预记录。
主要发现
- 研究期间197例患者共接受15,818个药物治疗日,记录1,572次药师干预,平均每例8次。
- 最常见干预为方案简化(15.9%)、时机与剂量调整(15.4%)、抗菌药物与COVID-19治疗调整(15.2%)。
- 住院期间任何时点入住ICU的患者占全部记录干预的66.7%。
临床怎么用
- 可参考将COVID-19专属care bundle嵌入电子病历,以标准化药师监护、跨专业沟通和干预记录。
- 药师应重点关注方案简化、给药时机与剂量调整以及抗感染治疗调整等高频干预类型。
- 对ICU患者应加强药学监护资源配置,因其占记录干预的多数。
局限性
- 为单中心回顾性描述性报告,仅覆盖2020年4月1日至15日,未设对照或评价干预对临床结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The global coronavirus disease 2019 (COVID-19) pandemic has created unprecedented strains on healthcare systems around the world. Challenges surrounding an overwhelming influx of patients with COVID-19 and changes in care dynamics prompt the need for care models and processes that optimize care in this medically complex patient population. The purpose of this report is to describe our institution's strategy to deploy pharmacy resources and standardize pharmacy processes to optimize the management of patients with COVID-19. METHODS: This retrospective, descriptive report characterizes documented pharmacy interventions in the acute care of patients admitted for COVID-19 during the period April 1 to April 15, 2020. Patient monitoring, interprofessional communication, and intervention documentation by pharmacy staff was facilitated through the development of a COVID-19-specific care bundle integrated into the electronic medical record. RESULTS: A total of 1,572 pharmacist interventions were documented in 197 patients who received a total of 15,818 medication days of therapy during the study period. The average number of interventions per patient was 8. The most common interventions were regimen simplification (15.9%), timing and dosing adjustments (15.4%), and antimicrobial therapy and COVID-19 treatment adjustments (15.2%). Patients who were admitted to an intensive care unit care at any point during their hospital stay accounted for 66.7% of all interventions documented. CONCLUSION: A pharmacy department's response to the COVID-19 pandemic was optimized through standardized processes. Pharmacists intervened to address a wide scope of medication-related issues, likely contributing to improved management of COVID-19 patients. Results of our analysis demonstrate the vital role pharmacists play as members of multidisciplinary teams during times of crisis.
引用
- Collins CD, West N, Sudekum DM, et al. Perspectives from the frontline: A pharmacy department's response to the COVID-19 pandemic. Am J Health Syst Pharm. 2020. PMID: 34279579. doi:10.1093/ajhp/zxaa176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。